BD (Becton, Dickinson and Company) announces that it has received 510(k) clearance and Clinical Laboratory Improvement Amendments (CLIA) waiver from the Food and Drug Administration (FDA) for the BD ...
FRANKLIN LAKES, N.J., Feb. 22, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Scanwell Health, a leader in smartphone-enabled ...
BD developed this new rapid, digitally read, lateral flow antigen self-test to make COVID-19 testing faster and easier for people to complete in the privacy and safety of their own homes. The test ...
BD (Becton, Dickinson and Company), a leading global medical technology company, has started to ship the first over-the-counter (OTC) Covid-19 rapid antigen test to use computer vision technology in a ...
BD (Becton, Dickinson and Company, a leading global medical company, announced the BD Veritor At-Home Covid-19 Test is now available for purchase through Everly Health, a digital health company at the ...
Becton, Dickinson and Company BDX, popularly known as BD, recently announced receipt of the FDA's Emergency Use Authorization ("EUA") for the BD Veritor At-Home COVID-19 Test. The test is an ...
MISSISSAUGA, ON, Nov. 10, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its rapid, point-of-care, SARS-CoV-2 antigen ...
BD (Becton, Dickinson and Company) (NYSE: BDX) has announced its rapid, point-of-care, SARS-CoV-2 antigen test for use on the BD Veritor™ Plus System has been CE marked to the IVD Directive (98/79/EC) ...